Serological evidence of West Nile virus infection in the horse population of northern Serbia

Strahinja Medić, Rene van den Hoven, Tamaš Petrović, Diana Lupulović, Norbert Nowotny

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: This study was conducted to evaluate the seroprevalence of West Nile virus (WNV) in the horse population of northern Serbia. Furthermore, it aimed to provide insight and an updated overview on the circulation of this re-emerging pathogen in this part of southeastern Europe. At the time of manuscript preparation, no clinical cases of WNV infection in horses were reported in this area. Methodology: Between 2007 and 2011, a total of 252 equine serum samples were collected from seven different locations in northern Serbia. The presence of WNV-reactive IgG antibodies was examined by using commercial and in-house ELISAs. Selected ELISA-positive samples were re-tested by a WNV lineage 2 plaque reduction neutralization test 90% (PRNT-90). Results: In 28.6% of the 252 tested equine serum samples antibodies against WNV were detected. The results obtained with the in-house ELISA corresponded to the outcome of the commercial kit in 90% of the samples. All selected WNV antibody ELISA-positive samples were confirmed by PRNT-90 with neutralizing antibody titers of 1:23 to > 1:512. Conclusion: This study confirms the circulation of WNV in northern Serbia. No striking regional differences in seroprevalences were identified suggesting WNV circulation also in other parts of Serbia. Distances between wetlands or forests and stud farms do not appear to have an influence on WNV seroprevalence.

Original languageEnglish
Pages (from-to)914-918
Number of pages5
JournalJournal of Infection in Developing Countries
Volume8
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Serbia
West Nile virus
Virus Diseases
Horses
Population
Seroepidemiologic Studies
Enzyme-Linked Immunosorbent Assay
Neutralization Tests
Antibodies
Manuscripts
Wetlands
Neutralizing Antibodies
Serum
Immunoglobulin G

Keywords

  • ELISA
  • Horse
  • Plaque reduction neutralization test
  • Serbia
  • Seroprevalence
  • West Nile virus

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology
  • Parasitology
  • Virology

Cite this

Serological evidence of West Nile virus infection in the horse population of northern Serbia. / Medić, Strahinja; van den Hoven, Rene; Petrović, Tamaš; Lupulović, Diana; Nowotny, Norbert.

In: Journal of Infection in Developing Countries, Vol. 8, No. 7, 2014, p. 914-918.

Research output: Contribution to journalArticle

Medić, Strahinja ; van den Hoven, Rene ; Petrović, Tamaš ; Lupulović, Diana ; Nowotny, Norbert. / Serological evidence of West Nile virus infection in the horse population of northern Serbia. In: Journal of Infection in Developing Countries. 2014 ; Vol. 8, No. 7. pp. 914-918.
@article{bca5a97033574582a3f2987e4bae279a,
title = "Serological evidence of West Nile virus infection in the horse population of northern Serbia",
abstract = "Introduction: This study was conducted to evaluate the seroprevalence of West Nile virus (WNV) in the horse population of northern Serbia. Furthermore, it aimed to provide insight and an updated overview on the circulation of this re-emerging pathogen in this part of southeastern Europe. At the time of manuscript preparation, no clinical cases of WNV infection in horses were reported in this area. Methodology: Between 2007 and 2011, a total of 252 equine serum samples were collected from seven different locations in northern Serbia. The presence of WNV-reactive IgG antibodies was examined by using commercial and in-house ELISAs. Selected ELISA-positive samples were re-tested by a WNV lineage 2 plaque reduction neutralization test 90{\%} (PRNT-90). Results: In 28.6{\%} of the 252 tested equine serum samples antibodies against WNV were detected. The results obtained with the in-house ELISA corresponded to the outcome of the commercial kit in 90{\%} of the samples. All selected WNV antibody ELISA-positive samples were confirmed by PRNT-90 with neutralizing antibody titers of 1:23 to > 1:512. Conclusion: This study confirms the circulation of WNV in northern Serbia. No striking regional differences in seroprevalences were identified suggesting WNV circulation also in other parts of Serbia. Distances between wetlands or forests and stud farms do not appear to have an influence on WNV seroprevalence.",
keywords = "ELISA, Horse, Plaque reduction neutralization test, Serbia, Seroprevalence, West Nile virus",
author = "Strahinja Medić and {van den Hoven}, Rene and Tamaš Petrović and Diana Lupulović and Norbert Nowotny",
year = "2014",
doi = "10.3855/jidc.3885",
language = "English",
volume = "8",
pages = "914--918",
journal = "Journal of Infection in Developing Countries",
issn = "1972-2680",
publisher = "Journal of Infection in Developing Countries",
number = "7",

}

TY - JOUR

T1 - Serological evidence of West Nile virus infection in the horse population of northern Serbia

AU - Medić, Strahinja

AU - van den Hoven, Rene

AU - Petrović, Tamaš

AU - Lupulović, Diana

AU - Nowotny, Norbert

PY - 2014

Y1 - 2014

N2 - Introduction: This study was conducted to evaluate the seroprevalence of West Nile virus (WNV) in the horse population of northern Serbia. Furthermore, it aimed to provide insight and an updated overview on the circulation of this re-emerging pathogen in this part of southeastern Europe. At the time of manuscript preparation, no clinical cases of WNV infection in horses were reported in this area. Methodology: Between 2007 and 2011, a total of 252 equine serum samples were collected from seven different locations in northern Serbia. The presence of WNV-reactive IgG antibodies was examined by using commercial and in-house ELISAs. Selected ELISA-positive samples were re-tested by a WNV lineage 2 plaque reduction neutralization test 90% (PRNT-90). Results: In 28.6% of the 252 tested equine serum samples antibodies against WNV were detected. The results obtained with the in-house ELISA corresponded to the outcome of the commercial kit in 90% of the samples. All selected WNV antibody ELISA-positive samples were confirmed by PRNT-90 with neutralizing antibody titers of 1:23 to > 1:512. Conclusion: This study confirms the circulation of WNV in northern Serbia. No striking regional differences in seroprevalences were identified suggesting WNV circulation also in other parts of Serbia. Distances between wetlands or forests and stud farms do not appear to have an influence on WNV seroprevalence.

AB - Introduction: This study was conducted to evaluate the seroprevalence of West Nile virus (WNV) in the horse population of northern Serbia. Furthermore, it aimed to provide insight and an updated overview on the circulation of this re-emerging pathogen in this part of southeastern Europe. At the time of manuscript preparation, no clinical cases of WNV infection in horses were reported in this area. Methodology: Between 2007 and 2011, a total of 252 equine serum samples were collected from seven different locations in northern Serbia. The presence of WNV-reactive IgG antibodies was examined by using commercial and in-house ELISAs. Selected ELISA-positive samples were re-tested by a WNV lineage 2 plaque reduction neutralization test 90% (PRNT-90). Results: In 28.6% of the 252 tested equine serum samples antibodies against WNV were detected. The results obtained with the in-house ELISA corresponded to the outcome of the commercial kit in 90% of the samples. All selected WNV antibody ELISA-positive samples were confirmed by PRNT-90 with neutralizing antibody titers of 1:23 to > 1:512. Conclusion: This study confirms the circulation of WNV in northern Serbia. No striking regional differences in seroprevalences were identified suggesting WNV circulation also in other parts of Serbia. Distances between wetlands or forests and stud farms do not appear to have an influence on WNV seroprevalence.

KW - ELISA

KW - Horse

KW - Plaque reduction neutralization test

KW - Serbia

KW - Seroprevalence

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=84904403724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904403724&partnerID=8YFLogxK

U2 - 10.3855/jidc.3885

DO - 10.3855/jidc.3885

M3 - Article

C2 - 25022304

AN - SCOPUS:84904403724

VL - 8

SP - 914

EP - 918

JO - Journal of Infection in Developing Countries

JF - Journal of Infection in Developing Countries

SN - 1972-2680

IS - 7

ER -